South Africa Cell and Gene Therapy Manufacturing QC Market Size
According to Straits Research analysis, the South Africa Cell and Gene Therapy Manufacturing QC Market was valued at USD 22.16 Million in 2024 and is projected to reach USD 45.07 Million by 2028, expanding at a CAGR of 19.3% during the forecast period. This growth is primarily driven by robust demand from the healthcare and medical research industries. Key sectors contributing to this demand include regenerative medicine, disease diagnosis, and treatment development. Meanwhile, advancements in biotechnology and genetic engineering present emerging opportunities for low-carbon production and sustainable practices. South Africa’s strong focus on exporting medical technologies also signifies promising growth potential. Looking ahead, South Africa continues to assert its strategic positioning in this market by fostering a strong research environment and supporting technological advancements in the field.
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market Highlights
- Cell Therapy held the leading position among Therapy Type segments in 2024, based on market size.
- Gene Therapy is projected to post the fastest growth rate, sustaining its position as the most attractive Therapy Type segment during the forecast horizon.
- In 2024, South Africa represented 0.99% of the overall global cell and gene therapy manufacturing qc market size.
- United States is projected to lead the global cell and gene therapy manufacturing qc market size by 2028.
- Across Middle East And Africa, Rest of MEA is anticipated to hold the dominant position in market by 2028.
- South Africa is forecasted to expand at the fastest pace in Middle East And Africa, attaining USD 5913 Million by 2028.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope |
Details |
| Base Year for Study |
2024 |
| Study Period |
2021-2028 |
| Historical Period |
2021-2023 |
| Forecast Period |
2025-2028 |
| Market Size In 2024 |
USD 22.16 Million |
| Market Size In 2028 |
USD 45.07 Million |
| Largest segment |
Cell Therapy |
| Fastest segment |
Gene Therapy |
| Units |
Revenue in USD Million |
| CAGR |
19.3% (2025-2028) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
South Africa Cell and Gene Therapy Manufacturing QC Market Share By Therapy Type
Segmentation Covered
| Segments |
Sub Segments |
| Therapy Type |
- Cell Therapy
- Gene Therapy
|
| Cell Therapy |
- CAR-T
- CAR-NK
- B-Cell
- Other
|
| CAR-T |
- Autologous CAR-T
- Allogeneic CAR-T
|
| Gene Therapy |
- Viral
- Non-Viral
|
| Viral |
- AAV
- Lentiviral vectors
- Other
|
| Scale |
- Pre commercial/ R&D Manufacturing
- Commercial Scale Manufacturing
|
| Mode |
- Contract Manufacturing
- In-house Manufacturing
|
| Workflow |
- Cell Processing
- Cell Banking
- Fill & Finish Operations
- Raw Material Testing
- Vector Production
- Other Workflows
|
| Process |
- Upstream Processes
- Downstream Processes
|
| End User |
- Pharmaceutical Companies
- Biopharmaceutical / Biotechnological Companies
- Contract Manufacturing Organizations
|
| Pharmaceutical Companies |
- Small Size
- Medium Size
- Large Size
|
| Biopharmaceutical / Biotechnological Companies |
- Small Size
- Medium Size
- Large Size
|
| Contract Manufacturing Organizations |
- Small Size
- Medium Size
- Large Size
|
| Technology Type |
- Fluorescence-Activated Cell Sorting (FACS)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chromatography
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Others
|
South Africa Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Cell Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By CAR-T 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Gene Therapy 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Viral 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Scale 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Mode 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Workflow 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Process 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By End User 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Pharmaceutical Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Biopharmaceutical / Biotechnological Companies 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Contract Manufacturing Organizations 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.
South Africa Cell and Gene Therapy Manufacturing QC Market By Technology Type 2028
Source: Straits Research Analysis Company Publications, Primary Interviews.